levosimendan at a dose of 6 mcg/kg

DRUG2 trials

Sponsors

Aretaieion University Hospital

Conditions

Cardiac FailureHypertension, PulmonaryPulmonary Vascular Resistance Abnormality

Unknown Phase

Levosimendan Administration in Pulmonary Hypertension

CompletedNCT04599816

Aretaieion University HospitalCardiac Failure, Hypertension, Pulmonary, Pulmonary Vascular Resistance Abnormality

Start: 2020-10-17End: 2022-10-17Updated: 2023-02-08

Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents

CompletedNCT04718350

Aretaieion University HospitalCardiac Failure, Hypertension, Pulmonary, Pulmonary Vascular Resistance Abnormality

Start: 2021-01-27End: 2023-12-30Updated: 2025-07-22